Type / Class
Equity / American Depositary Shares, each representing 1 Ordinary Shares
Shares outstanding
100M
Number of holders
75
Total 13F shares, excl. options
13.9M
Shares change
-544K
Total reported value, excl. options
$246M
Value change
-$7.13M
Number of buys
45
Number of sells
-27
Price
$17.80

Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q2 2020

85 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q2 2020.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13.9M shares of 100M outstanding shares and own 13.8% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (2.78M shares), Capital International Investors (1.34M shares), FMR LLC (1.08M shares), CAPITAL INTERNATIONAL INC (988K shares), Capital World Investors (875K shares), MORGAN STANLEY (800K shares), Sumitomo Mitsui Trust Holdings, Inc. (737K shares), Nikko Asset Management Americas, Inc. (728K shares), CREDIT SUISSE AG/ (700K shares), and MILLENNIUM MANAGEMENT LLC (312K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.